Get started
Author

Freda Qi

Observed names: Freda W. Qi, Fredo Qi, Qi, Freda
Observed institutions: Western University, Mount Sinai Hospital, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Public Health Ontario, Sinai Health System
ORCID: 0000-0002-2859-3667
Observed ORCID: 0000-0002-2859-3667
OpenAlex ID: A5083950709
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
2023 · Vitaliy A. Matveev, Erik Z. Mihelic, et al. · iScience · 27
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
2023 · Javier T Solera, Matthew Ierullo, et al. · The Lancet Infectious Diseases · 25
PDF
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients
2023 · Kevin Yau, Paul Tam, et al. · Clinical Journal of the American Society of Nephrology · 11
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
2025 · Philip Samaan, Chapin S. Korosec, et al. · Journal of Virology · 10
RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling
2023 · Cornelia Tolg, Maja Milojevic, et al. · Breast Cancer Research · 10
PDF
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
2024 · Sharon Walmsley, Majid Nabipoor, et al. · Vaccines · 9
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease
2023 · Kevin Yau, Alexandra Kurtesi, et al. · Nature Communications · 8
PDF
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
2025 · Jun Liu, Li Wang, et al. · npj Vaccines · 7
PDF
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study
2024 · Patrick E. Brown, Sze Hang Fu, et al. · eLife · 6
Reduced vaccine-induced germinal center outputs in patients with inflammatory bowel disease treated with anti-TNF biologics
2025 · Michelle W. Cheung, Samantha Xu, et al. · Journal of Clinical Investigation · 5
PDF
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS‐CoV‐2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4 + T‐Cell Activity
2025 · Victor H. Ferreira, Brandon Keith, et al. · Transplant Infectious Disease · 3
PDF
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
2024 · Gregory Morgan, Chun Yiu Jordan Fung, et al. · Clinical Biochemistry · 3
Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020–2023
2025 · Brenda L. Coleman, Nicole M. Robertson, et al. · Epidemiology and Infection · 2
PDF
Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia
2026 · Sabryna Nantel, Samuel Sassine, et al. · npj Vaccines · 1
PDF
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
2024 · Jacklyn R. Hurst, Maedeh Naghibosadat, et al. · PLoS ONE · 1
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study
2024 · Omosomi Enilama, Kevin Yau, et al. · Canadian Journal of Kidney Health and Disease · 1
Immunogenicity of COVID-19 Vaccines and Their Effect on the HIV Reservoir in Older People with HIV
2023 · Vitaliy A. Matveev, Erik Z. Mihelic, et al. · SSRN Electronic Journal · 1
Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study
2026 · Christopher Kandel, Jessica A Breznik, et al. · The Lancet Microbe
SARS-CoV-2 infection in female sex workers from Nairobi, Kenya early in the COVID-19 pandemic: Seroincidence and behavioural associations
2026 · Su D. Yang, Freda Qi, et al. · PLoS ONE
PDF
Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
2026 · Janna R. Shapiro, Freda Qi, et al. · Pediatric Blood & Cancer
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIV
2026 · Sharon L. Walmsley, Leif Erik Lovblom, et al. · Antibodies
PDF
Neutralising antibody responses to emerging SARS ‐ CoV ‐2 omicron sub‐variants are enhanced in persons with hybrid immunity
2026 · Sharon L Walmsley, Majid Nabipoor, et al. · Clinical & Translational Immunology
Altered germinal center outputs to SARS-CoV-2 mRNA vaccination in inflammatory bowel disease patients treated with anti-TNF biologics 2707
2025 · Michelle W Cheung, Samantha Xu, et al. · The Journal of Immunology
PDF
Comparison of six COVID-19 serology assays for detection of antibodies from patients infected with ancestral and a spectrum of SARS-CoV-2 variants
2025 · Rachel Lau, Chandrika Senthilkumaran, et al. · Access Microbiology
PDF
P-2051. Assessing SARS-CoV-2 Correlates Protection from Exposed Household Members: A Prospective Cohort Study (AB-PROTECT Study)
2025 · Christopher Kandel, Maureen Taylor, et al. · Open Forum Infectious Diseases
Works count: 32
Citation count: 130
H-index: 7
I10-index: 5
Year
Topic
Type